EUROPE SMART INHALERS MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • EUROPE SMART INHALERS MARKET FORECAST 2019-2028

EUROPE SMART INHALERS MARKET FORECAST 2019-2028

The Europe smart inhalers market is anticipated to register a CAGR of 32.11% during the forecast period, 2019-2028. The adoption of smart inhalers by healthcare professionals and patients, an increase in the use of healthcare services, a rise in the incidence of respiratory allergies and asthma, a surge in hospitalizations, and medication costs are stimulating market growth in the region.

EUROPE SMART INHALERS MARKET FORECAST 2019-2028

Europe Smart Inhalers Market by Product (Smart Inhalers, Smart Nebulizer (Types of Nebulizer (Qualitative), Nebulizer by Portability (Qualitative), Nebulizer by Sales Channel (Qualitative))) by Indication (Asthma, Copd) by Distribution Channel (Hospital, Pharmacy) and by Geography.

Request free sample

The Europe smart inhalers market is anticipated to register a CAGR of 32.11% during the forecast period, 2019-2028. The adoption of smart inhalers by healthcare professionals and patients, an increase in the use of healthcare services, a rise in the incidence of respiratory allergies and asthma, a surge in hospitalizations, and medication costs are stimulating market growth in the region.
Europe Smart Inhalers Market

To know more about this report, request a free sample copy

The Europe smart inhalers market growth potential is researched by segregating the region into Germany, Russia, the UK, France, Belgium, Italy, Poland, and the rest of Europe. Germany spends around 11% of the GDP on healthcare per capita every year, according to OECD. The well-established healthcare infrastructure, substantial healthcare expenditure, and high hospital admission rates steer market growth.  In France, the growing incidence of respiratory diseases and increasing government expenditure to fight respiratory diseases, with initiatives to develop better disease-restraining models, drive the demand for the smart inhalers market.

In countries like the UK, there are about 5.4 million people with asthma, implying one in every 11 people and one in five households, according to Asthma UK. Moreover, 1.2 million people are diagnosed with COPD, and more than 0.15 million people are diagnosed with interstitial lung disease. The medical sector has developed remarkably in the last few years.  In Russia, a report observed COPD occurrence of 15.3% in 12 regions related to high rates of smoking among the Russian population. Moreover, the incidence of cystic fibrosis is 1 per every 10,000 births as per available official data. The surge in the occurrence rate of COPD and cystic fibrosis is predicted to fuel market growth.

Boehringer Ingelheim International GmbH, headquartered in Ingelheim am Rhein, Germany, is a pharmaceutical company involved in the manufacture, R&D of pharmaceutical products. In Feb 2020, the company announced that the CHMP accepted a recommendation, which granted marketing authorization for the treatment of SSc-ILD in adults.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • RISE IN AIR POLLUTION
      • HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES
      • SURGING INDOOR AIR POLLUTANTS
      • RISING GERIATRIC POPULATION
      • GROWING PREVALENCE OF COPD AND ASTHMA
    •    KEY RESTRAINTS
      • DATA SECURITY CONCERN HAMPERS THE MARKET
      • HIGH COST OF ASTHMA AND COPD TREATMENT
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • EVOLUTION OF SMART INHALERS
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY PRODUCT
    • SMART INHALERS
    •    SMART NEBULIZER
      •    TYPES OF NEBULIZER (QUALITATIVE)
        • PNEUMATIC NEBULIZER
        • ULTRASONIC NEBULIZER
        • MESH NEBULIZER
      •    NEBULIZER BY PORTABILITY (QUALITATIVE)
        • TABLETOP NEBULIZER
        • PORTABLE NEBULIZER
      •    NEBULIZER BY SALES CHANNEL (QUALITATIVE)
        • DIRECT PURCHASE
        • ONLINE PURCHASE
  1. MARKET BY INDICATION
    • ASTHMA
    • COPD
  2. MARKET BY DISTRIBUTION CHANNEL
    • HOSPITAL
    • PHARMACY
  3. GEOGRAPHICAL ANALYSIS
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. COMPANY PROFILES
    • 3M COMPANY
    • ADHERIUM LIMITED
    • AGILENT TECHNOLOGIES INC
    • ASTRAZENECA PLC
    • BOEHRINGER INGELHEIM GMBH
    • COHERO HEALTH INC
    • GLAXOSMITHKLINE PLC
    • KONINKLIJKE PHILIPS N.V.
    • NOVARTIS AG
    • OPKO HEALTH INC
    • RESMED INC (PROPELLER HEALTH)
    • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
    • VECTURA GROUP PLC

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – SMART INHALERS

TABLE 2: EUROPE SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 3: EUROPE SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 4: EUROPE SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 5: EUROPE SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 6: EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 7: EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

TABLE 8: EUROPE SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)

TABLE 9: EUROPE SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: KEY INVESTMENT INSIGHTS

FIGURE 5: EUROPE SMART INHALERS MARKET, BY PRODUCT, IN 2019

FIGURE 6: EUROPE SMART INHALERS MARKET, BY SMART INHALERS, 2019-2028 (IN $ THOUSAND)

FIGURE 7: EUROPE SMART INHALERS MARKET, BY SMART NEBULIZER, 2019-2028 (IN $ THOUSAND)

FIGURE 8: EUROPE SMART INHALERS MARKET, BY INDICATION, IN 2019

FIGURE 9: EUROPE SMART INHALERS MARKET, BY ASTHMA, 2019-2028 (IN $ THOUSAND)

FIGURE 10: EUROPE SMART INHALERS MARKET, BY COPD, 2019-2028 (IN $ THOUSAND)

FIGURE 11: EUROPE SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, IN 2019

FIGURE 12: EUROPE SMART INHALERS MARKET, BY HOSPITAL, 2019-2028 (IN $ THOUSAND)

FIGURE 13: EUROPE SMART INHALERS MARKET, BY PHARMACY, 2019-2028 (IN $ THOUSAND)

FIGURE 14: EUROPE SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 15: GERMANY SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 16: FRANCE SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 17: THE UNITED KINGDOM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 18: ITALY SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 19: RUSSIA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 20: BELGIUM SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 21: POLAND SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

FIGURE 22: REST OF EUROPE SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)

  1. GEOGRAPHICAL ANALYSIS
    •    EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. MARKET BY PRODUCT
    • SMART INHALERS
    •    SMART NEBULIZER
      •    TYPES OF NEBULIZER (QUALITATIVE)
        • PNEUMATIC NEBULIZER
        • ULTRASONIC NEBULIZER
        • MESH NEBULIZER
      •    NEBULIZER BY PORTABILITY (QUALITATIVE)
        • TABLETOP NEBULIZER
        • PORTABLE NEBULIZER
      •    NEBULIZER BY SALES CHANNEL (QUALITATIVE)
        • DIRECT PURCHASE
        • ONLINE PURCHASE
  1. MARKET BY INDICATION
    • ASTHMA
    • COPD
  2. MARKET BY DISTRIBUTION CHANNEL
    • HOSPITAL
    • PHARMACY

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now